Atlas Trials

Study to Evaluate Efficacy and Safety of Inhaled BEA 2180 BR in COPD Patients

Clinical trial NCT02242279 · COMPLETED

Trial details

NCT number
NCT02242279
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary Disease, Chronic Obstructive
Start date
2004-06-01
Primary completion
2004-12-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.